Ophthalmic Dispensers Recommended Class I Designation By FDA Panel
…and the first tangible impacts of the Genus vs. FDA decision
The FDA’s Ophthalmic Devices Panel approved a Class I designation for ophthalmic dispensers, which were reclassified from drugs to devices after the Genus v. FDA decision.
You may also be interested in...
The General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee will meet from 26-27 October, and the Ophthalmic Devices Panel of the Medical Devices Advisory Committee will meet 10 November.
After losing the recent Genus Medical Technologies court case, the US FDA will begin transitioning certain imaging agent drugs to devices. Because user-fee deadlines for drugs and generics are approaching, the agency says firms should pay those fees now and ask for a refund after the transition.
In the second trial over Sterigenics’ ethylene oxide plant emissions, the Cook County, IL jury found Stergiencs not liable for cancer in a woman who lived near the plant.